AR-1006

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameAR-1006
Drug Alias NameAR1006AR-1006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLupus Erythematosus, SystemicRett Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAribio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAribio Co Ltd
Inactive CompaniesN/A
Active IndicationsRett Syndrome
Inactive IndicationsLupus Erythematosus, Systemic

Other Information

ATC CodeN/A
Related LinksN/A